Think of Retatrutide as creating an opportunity window
Why Retatrutide Stopped Working Isn't What You Think The most common mistake is treating Retatrutide like a switch
In clinical trials involving 17,183 patients, 50.2% of participants treated with GLP-1 receptor agonists lost at least 5% of their body weight, and 17.5% achieved a weight loss of 10% or more, both figures being significant compared to a placebo group
While the results of GLP-1 medications and their on-brand usage are generally positive, the rapid improvements in blood sugar levels should remain a concern for ophthalmologists
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral
Remember, GLP-1 medications slow down digestion, so you might need to revisit your dosing with your doctor if symptoms persist